ASX - By Stock
|
PYC |
Re:
Ann: Q2 2024 Investor Webinar Presentation
|
|
Eaglenebula
|
23 |
5.9K |
3 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
23
|
5.9K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q2 2024 Investor Webinar Presentation
|
|
Eaglenebula
|
23 |
5.9K |
22 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
23
|
5.9K
|
22
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
Eaglenebula
|
23 |
14K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
23
|
14K
|
4
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
3 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
126
|
53K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Presentation of RP11 Clinical Trial Data at ARVO Conference
|
|
Eaglenebula
|
9 |
3.7K |
7 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
9
|
3.7K
|
7
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
1 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
126
|
53K
|
1
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
0 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
126
|
53K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Drug Candidate Progressing to Mid-Stage Human Trials
|
|
Eaglenebula
|
14 |
5.8K |
14 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
14
|
5.8K
|
14
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
266
|
118K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
266
|
118K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
9 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
266
|
118K
|
9
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
3 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
266
|
118K
|
3
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
126
|
53K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
266
|
118K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
266
|
118K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
266
|
118K
|
1
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
126
|
53K
|
1
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
126
|
53K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
41 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
266
|
118K
|
41
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
7 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
126
|
53K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: $74.6 Million Extension of Cash Runway
|
|
Eaglenebula
|
15 |
5.0K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
15
|
5.0K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: $74.6 Million Extension of Cash Runway
|
|
Eaglenebula
|
15 |
5.0K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
15
|
5.0K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
266
|
118K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
266
|
118K
|
1
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
6 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
126
|
53K
|
6
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
11 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
126
|
53K
|
11
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
126
|
53K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Change of Director's Interest Notice
|
|
Eaglenebula
|
12 |
4.1K |
3 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
12
|
4.1K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Change of Director's Interest Notice
|
|
Eaglenebula
|
12 |
4.1K |
2 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
12
|
4.1K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
266
|
118K
|
0
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Eaglenebula
|
126 |
53K |
2 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
126
|
53K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
1 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
266
|
118K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
18 |
14/01/24 |
14/01/24 |
ASX - By Stock
|
266
|
118K
|
18
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
5 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
266
|
118K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
5 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
266
|
118K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Eaglenebula
|
23K |
11M |
15 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
23K
|
11M
|
15
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
0 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
266
|
118K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Eaglenebula
|
266 |
118K |
1 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
266
|
118K
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Eaglenebula
|
32K |
15M |
1 |
05/12/23 |
05/12/23 |
Charts
|
32K
|
15M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Eaglenebula
|
32K |
15M |
26 |
05/12/23 |
05/12/23 |
Charts
|
32K
|
15M
|
26
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA Fast Track Designation Granted for VAXINIA Trial Program
|
|
Eaglenebula
|
412 |
172K |
63 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
412
|
172K
|
63
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Eaglenebula
|
32K |
15M |
15 |
27/11/23 |
27/11/23 |
Charts
|
32K
|
15M
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Eaglenebula
|
23K |
11M |
49 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
23K
|
11M
|
49
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Polycystic Kidney Disease Program Presentation
|
|
Eaglenebula
|
10 |
5.0K |
8 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
10
|
5.0K
|
8
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Eaglenebula
|
32K |
15M |
1 |
11/11/23 |
11/11/23 |
Charts
|
32K
|
15M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Eaglenebula
|
23K |
11M |
5 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
23K
|
11M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Eaglenebula
|
23K |
11M |
32 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
23K
|
11M
|
32
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Eaglenebula
|
32K |
15M |
36 |
08/11/23 |
08/11/23 |
Charts
|
32K
|
15M
|
36
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx
|
|
Eaglenebula
|
180 |
105K |
57 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
180
|
105K
|
57
|
|
ASX - By Stock
|
VMS |
Re:
Ann: Tin Drilling Discovers Large Mineralised Skarn near Renison
|
|
Eaglenebula
|
226 |
71K |
1 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
226
|
71K
|
1
|
|